Executive Summary
22 significant contract modifications totaling $3.4B highlight robust federal demand for IT services (9 contracts, ~$1.7B), construction/infrastructure (~$1.1B), and biotech/space R&D (~$0.5B), with public firms Booz Allen Hamilton ($818M), Lockheed Martin ($79M), and Textron ($134M) gaining largest backlogs. All but 3 signals are bullish, driven by multi-year obligations and unexercised options exceeding $2B across portfolio. Risks concentrate on firm-fixed-price cost overruns (12/22 contracts) and low outlays ($0 in 8 cases), warranting monitoring of FY2026 funding.
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from February 19, 2026.
Investment Signals(5)
- IT Services Backlog Surge(HIGH)▲
9 contracts totaling $1.7B in NAICS 541512/541330 awarded/modified, led by Booz Allen ($818M total), Peraton ($211M), SAIC ($59M).
- Construction Revenue Commitments(HIGH)▲
Clark ($616M hospital) and Kiewit ($242M Hurricane Helene bridges/highways) secure $858M in design-build work through 2028.
- Biothreat Biotech Funding(MEDIUM)▲
Paratek ($265M antibiotic to 2029) and Luminary Labs ($100M R&D to 2028) gain $365M HHS/BARDA awards amid health security push.
- NASA Space Longevity(HIGH)▲
Lockheed Martin secures $74M + $5M for GEOXO Lightning Mapper (to 2049) and lunar studies, signaling decades-long R&D pipeline.
- Aviation Manufacturing Demand(MEDIUM)▲
Textron Aviation ($134M obligated, $283M potential) for 18 FAA Beechcraft aircraft through 2031 underscores federal fleet sustainment.
Risk Flags(4)
- Execution[HIGH RISK]▼
Firm-fixed-price structures in 12 contracts (~$2B) expose contractors to cost overruns in construction, R&D, manufacturing amid inflation/delays.
- Execution[MEDIUM RISK]▼
$0 outlays in 8 contracts ($585M total obligation) signal potential funding delays or non-starts.
- Market[MEDIUM RISK]▼
Heavy subawards (e.g., Peraton $258M/53 subs, Amentum 70/$16M) create dependency risks on subcontractor execution.
- Execution[HIGH RISK]▼
Long horizons (e.g., Lockheed to 2049, Textron to 2031) vulnerable to budget shifts, tech changes.
Opportunities(4)
- ◆
Unexercised options exceed $2B (e.g., Peraton $142M, SAIC $268M, Lockheed $297M), potentially doubling obligated values.
- ◆
GSA vehicle expansions (8 contracts, $1.2B) position winners for follow-ons in IT/engineering.
- ◆
Disaster recovery (Kiewit Helene $242M) and fire retardant (Perimeter $64M fully outlayed) signal seasonal repeat business.
- ◆
BARDA biothreat prizes (Paratek/Luminary $365M) open doors for small biz in health security R&D.
Sector Themes(4)
- ◆
13 contracts ($2B+) in NAICS 541512/541330 via GSA/VA/DHS underscore multi-year modernization spend.
- ◆
Hospital (Clark) and disaster repair (Kiewit) total $858M reflect IIJA/DRF priorities through 2028.
- ◆
NASA/Lockheed/Textron deals to 2049/2031 signal Artemis/GEO sustained investment.
- ◆
$365M HHS awards to 2029 highlight biothreat antibiotic/platform priorities.
Watch List(4)
- 👁
{"entity"=>"Booz Allen Hamilton (BAH)", "reason"=>"Largest winner ($818M GSA/VA IT), but dual FFP/T&M mix with expiring periods.", "trigger"=>"Q2 2026 10-Q backlog/outlay updates"}
- 👁
{"entity"=>"Lockheed Martin (LMT)", "reason"=>"$79M NASA adds to space pipeline, but 25yr horizon needs option milestones.", "trigger"=>"NASA FY2027 budget; GEOXO progress"}
- 👁
{"entity"=>"Peraton/SAIC IT Vehicles", "reason"=>"$270M+ options in DHS/GSA IT; subaward/heavy reliance flags margins.", "trigger"=>"Outlay acceleration or stop-work resolutions"}
- 👁
{"entity"=>"Kiewit/Clark Construction", "reason"=>"$858M infra, but FFP overruns in design-build/hospitals.", "trigger"=>"2026 site progress reports"}
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 22 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC